Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
factor-xii
Press Release
Dec 2, 2020
Aronora Announces Clinical Data to Be Presented at the 62nd American Society of Hematology Annual Meeting
Presentation to include clinical data from Aronora's phase 2 study of AB023, a factor XI-targeted antibody that is being developed for the treatment and prevention of thrombosis and inflammation.
Read More
First
Prev
1
Next
Last
